NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Octarine Bio

Octarine Bio

Private
CopenhagenHealthcare & Life Scienceshttps://www.octarinebio.com/

Last Round

Series A

Extension

Jan 22, 2026

Total Funding Raised

$13.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Octarine Bio is a biotechnology company that develops sustainable, bio-based pigments and dyes for the textile, food, and personal care industries using synthetic biology and precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

synthetic biologyprecision fermentationbio-based pigmentssynbiosustainable dyesmicrobial strain engineeringbiocatalysisenzymatic enhancementsustainable materialsclean manufacturinggreen chemistrybio-based ingredientsindustrial biotechcell factory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octarine Bio Comps

Public and private peers based on sector, stage, and business model.

Octarine Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Octarine Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 22, 2026
Series ANov 8, 2023
VC RoundSep 21, 2022
SeedMar 13, 2021
SeedNov 12, 2020
Pre Seed
Jan 10, 2020

Key People

Founding team and executive leadership

Nethaji Gallage

Board Member, Founder, CEO

Founding Team

Jan Villadsen

CFO

Executive Team

Octarine Bio Investors

Notable investors and investment history

Octarine Bio investors
InvestorRounds
EdaphonSeries A Extension
Unconventional VenturesSeries A Extension, Series A
The Footprint FirmSeries A, Series A Extension
Óskare CapitalSeries A, Series A Extension, Seed, VC Round
The Export and Investment Fund of DenmarkSeed
DSM VenturingVC Round
ENEXISSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    $15.3M round completed.

Octarine Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Octarine Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Octarine Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range30
Year Founded2018
Last FundingJan 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.